Teladoc Health (NYSE:TDOC) Price Target Cut to $15.00

Teladoc Health (NYSE:TDOC - Get Free Report) had its price objective cut by equities research analysts at Wells Fargo & Company from $17.00 to $15.00 in a research note issued to investors on Monday, Benzinga reports. The firm presently has an "equal weight" rating on the health services provider's stock. Wells Fargo & Company's price target points to a potential upside of 11.98% from the stock's current price.

Several other equities research analysts have also issued reports on the company. Leerink Partnrs reaffirmed a "market perform" rating on shares of Teladoc Health in a research report on Monday, February 26th. Truist Financial decreased their target price on Teladoc Health from $23.00 to $17.00 and set a "hold" rating for the company in a research report on Wednesday, March 6th. SVB Leerink started coverage on Teladoc Health in a research report on Monday, February 26th. They set a "market perform" rating and a $17.00 target price for the company. Royal Bank of Canada decreased their target price on Teladoc Health from $25.00 to $18.00 and set an "outperform" rating for the company in a research report on Friday. Finally, Evercore ISI cut their price target on Teladoc Health from $15.00 to $14.00 and set an "in-line" rating for the company in a research note on Friday. Twelve analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $18.73.

Teladoc Health Stock Up 3.0 %

NYSE TDOC traded up $0.38 on Monday, reaching $13.40. The company had a trading volume of 6,521,453 shares, compared to its average volume of 4,819,929. The stock has a market capitalization of $2.27 billion, a P/E ratio of -9.50 and a beta of 0.94. The company's fifty day moving average is $14.69 and its 200 day moving average is $17.67. Teladoc Health has a 52-week low of $12.65 and a 52-week high of $30.41. The company has a quick ratio of 3.47, a current ratio of 3.54 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). The company had revenue of $646.13 million during the quarter, compared to analysts' expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The company's quarterly revenue was up 2.7% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.37) earnings per share. Sell-side analysts anticipate that Teladoc Health will post -1.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Andrew Turitz sold 6,190 shares of the firm's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares of the company's stock, valued at approximately $572,509.08. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, insider Daniel Trencher sold 6,780 shares of the firm's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total transaction of $98,445.60. Following the transaction, the insider now directly owns 28,192 shares of the company's stock, valued at approximately $409,347.84. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Andrew Turitz sold 6,190 shares of the firm's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the transaction, the executive vice president now directly owns 39,429 shares in the company, valued at $572,509.08. The disclosure for this sale can be found here. Insiders sold a total of 135,441 shares of company stock worth $2,038,251 in the last quarter. 0.95% of the stock is owned by company insiders.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of the stock. Newbridge Financial Services Group Inc. increased its stake in Teladoc Health by 2,130.9% in the 1st quarter. Newbridge Financial Services Group Inc. now owns 11,400 shares of the health services provider's stock worth $172,000 after purchasing an additional 10,889 shares during the period. Westside Investment Management Inc. increased its stake in Teladoc Health by 37.7% in the 1st quarter. Westside Investment Management Inc. now owns 5,662 shares of the health services provider's stock worth $85,000 after purchasing an additional 1,550 shares during the period. Allspring Global Investments Holdings LLC increased its stake in Teladoc Health by 74.0% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider's stock worth $311,000 after purchasing an additional 8,750 shares during the period. Counterpoint Mutual Funds LLC purchased a new position in shares of Teladoc Health during the first quarter valued at approximately $271,000. Finally, Ignite Planners LLC increased its stake in shares of Teladoc Health by 6.9% during the first quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider's stock valued at $198,000 after buying an additional 857 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.